FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118313809> ?p ?o ?g. }

• W2118313809 endingPage "4128" @default.
• W2118313809 startingPage "4121" @default.
• W2118313809 abstract "Purpose Platinum-based regimens are the standard chemotherapy for patients with advanced non–small-cell lung cancer (NSCLC). DNA repair capacity (DRC) in tumor cells plays an important role in resistance to platinum-based drugs. We have previously reported that efficient DRC, as assessed by an in vitro lymphocyte-based assay, was a determinant of poor survival in patients with NSCLC in a relatively small data set. In this larger independent study of 591 patients with NSCLC, we further evaluated whether DRC in peripheral lymphocytes predicts survival of patients with NSCLC who receive platinum-based chemotherapy. Patients and Methods All patients were recruited at The University of Texas MD Anderson Cancer Center and donated blood samples before the start of any chemotherapy. We measured DRC in cultured T lymphocytes by using the host-cell reactivation assay, and we assessed associations between DRC in peripheral lymphocytes and survival of patients with NSCLC who were treated with first-line platinum-based chemotherapy. Results We found an inverse association between DRC in peripheral lymphocytes and patient survival. Compared with patients in the low tertile of DRC, patients with NSCLC in the high tertile of DRC had significantly worse overall and 3-year survival (adjusted hazard ratio [HR], 1.33; 95% CI, 1.04 to 1.71; P = .023; and HR, 1.35; 95% CI, 1.04 to 1.76; P = .025, respectively). This trend was more pronounced in patients with early-stage tumors, adenocarcinoma, or squamous cell carcinoma. Conclusion We confirmed that DRC in peripheral lymphocytes is an independent predictor of survival for patients with NSCLC treated with platinum-based chemotherapy." @default.
• W2118313809 created "2016-06-24" @default.
• W2118313809 creator A5004805369 @default.
• W2118313809 creator A5012002845 @default.
• W2118313809 creator A5016774887 @default.
• W2118313809 creator A5028989565 @default.
• W2118313809 creator A5029023607 @default.
• W2118313809 creator A5035156015 @default.
• W2118313809 creator A5060545230 @default.
• W2118313809 creator A5076225093 @default.
• W2118313809 date "2011-11-01" @default.
• W2118313809 modified "2023-10-17" @default.
• W2118313809 title "DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy" @default.
• W2118313809 cites W1586119447 @default.
• W2118313809 cites W181871780 @default.
• W2118313809 cites W1963528972 @default.
• W2118313809 cites W1996509942 @default.
• W2118313809 cites W2004288169 @default.
• W2118313809 cites W2008514009 @default.
• W2118313809 cites W2014260980 @default.
• W2118313809 cites W2017194759 @default.
• W2118313809 cites W2020945961 @default.
• W2118313809 cites W2021781410 @default.
• W2118313809 cites W2025254447 @default.
• W2118313809 cites W2056184557 @default.
• W2118313809 cites W2057720971 @default.
• W2118313809 cites W2058977958 @default.
• W2118313809 cites W2061136895 @default.
• W2118313809 cites W2062093570 @default.
• W2118313809 cites W2080883315 @default.
• W2118313809 cites W2081086432 @default.
• W2118313809 cites W2092160717 @default.
• W2118313809 cites W2099082193 @default.
• W2118313809 cites W2104896412 @default.
• W2118313809 cites W2107337761 @default.
• W2118313809 cites W2116163715 @default.
• W2118313809 cites W2126854707 @default.
• W2118313809 cites W2135114425 @default.
• W2118313809 cites W2137979018 @default.
• W2118313809 cites W2146400693 @default.
• W2118313809 cites W2156199415 @default.
• W2118313809 cites W2156380335 @default.
• W2118313809 cites W2165042129 @default.
• W2118313809 cites W2165522199 @default.
• W2118313809 cites W2170454539 @default.
• W2118313809 cites W2172916891 @default.
• W2118313809 cites W2179627804 @default.
• W2118313809 doi "https://doi.org/10.1200/jco.2010.34.3616" @default.
• W2118313809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3675702" @default.
• W2118313809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21947825" @default.
• W2118313809 hasPublicationYear "2011" @default.
• W2118313809 type Work @default.
• W2118313809 sameAs 2118313809 @default.
• W2118313809 citedByCount "58" @default.
• W2118313809 countsByYear W21183138092012 @default.
• W2118313809 countsByYear W21183138092013 @default.
• W2118313809 countsByYear W21183138092014 @default.
• W2118313809 countsByYear W21183138092015 @default.
• W2118313809 countsByYear W21183138092016 @default.
• W2118313809 countsByYear W21183138092017 @default.
• W2118313809 countsByYear W21183138092018 @default.
• W2118313809 countsByYear W21183138092019 @default.
• W2118313809 countsByYear W21183138092021 @default.
• W2118313809 countsByYear W21183138092022 @default.
• W2118313809 countsByYear W21183138092023 @default.
• W2118313809 crossrefType "journal-article" @default.
• W2118313809 hasAuthorship W2118313809A5004805369 @default.
• W2118313809 hasAuthorship W2118313809A5012002845 @default.
• W2118313809 hasAuthorship W2118313809A5016774887 @default.
• W2118313809 hasAuthorship W2118313809A5028989565 @default.
• W2118313809 hasAuthorship W2118313809A5029023607 @default.
• W2118313809 hasAuthorship W2118313809A5035156015 @default.
• W2118313809 hasAuthorship W2118313809A5060545230 @default.
• W2118313809 hasAuthorship W2118313809A5076225093 @default.
• W2118313809 hasBestOaLocation W21183138091 @default.
• W2118313809 hasConcept C121608353 @default.
• W2118313809 hasConcept C126322002 @default.
• W2118313809 hasConcept C143998085 @default.
• W2118313809 hasConcept C207103383 @default.
• W2118313809 hasConcept C2776256026 @default.
• W2118313809 hasConcept C2776694085 @default.
• W2118313809 hasConcept C2777761686 @default.
• W2118313809 hasConcept C2781182431 @default.
• W2118313809 hasConcept C44249647 @default.
• W2118313809 hasConcept C71924100 @default.
• W2118313809 hasConcept C90924648 @default.
• W2118313809 hasConceptScore W2118313809C121608353 @default.
• W2118313809 hasConceptScore W2118313809C126322002 @default.
• W2118313809 hasConceptScore W2118313809C143998085 @default.
• W2118313809 hasConceptScore W2118313809C207103383 @default.
• W2118313809 hasConceptScore W2118313809C2776256026 @default.
• W2118313809 hasConceptScore W2118313809C2776694085 @default.
• W2118313809 hasConceptScore W2118313809C2777761686 @default.
• W2118313809 hasConceptScore W2118313809C2781182431 @default.
• W2118313809 hasConceptScore W2118313809C44249647 @default.
• W2118313809 hasConceptScore W2118313809C71924100 @default.
• W2118313809 hasConceptScore W2118313809C90924648 @default.
• W2118313809 hasIssue "31" @default.

• next